Featured Article

Blood-based microRNA (miRNA) tests could diagnose mild cognitive deficits and predict the progression to Alzheimer’s disease years before it manifests clinically, research suggests.

Precision Oncology Today

Magazine

Applying Precision Technology to Tackle Climate-Driven Infectious Diseases

The devastating impact that infectious diseases can have on the global population was well demonstrated by the COVID-19 pandemic. Fortunately, pandemics remain unusual occurrences, but research suggests that factors such as climate change may be increasing the risk of such events occurring in the future. Integrative projects that simultaneously tackle infectious disease risks, climate change, and other environmental issues could help solve a complicated global problem.
Blood Testing

Minimal Disease, Maximum Benefit

As both flow cytometry technology and genomic sequencing have taken technological leaps forward, the sensitivity and specificity of testing has increased to include MRD for solid tumors. Leveraging advances in next-generation sequencing, MRD test developers can look for thousands of disease markers and even detect one cancerous cell among a million healthy cells. This level of sensitivity provides evidence of disease recurrence months before traditional follow-up screening methods.
Antibodies Background

Immunogenomics is on the Way Up

Combining immune-system science, omics, and various computational algorithms might produce success where advanced cancer treatments have failed.

Trending on Inside Precision Medicine

Three young black women standing next to each other to symbolize that they may be at different risks for breast cancer recurrence to people of other ethnicities.

Black Women Face Higher Risk of Death from All Breast Cancer Types

Researchers from the Mass General Brigham have revealed that Black women face a higher risk of dying from breast cancer than White women across all tumor subtypes.
Middle aged man with type 2 diabetes using blood sugar measurement device to monitor type 2 diabetes, which is often treated with SGLT2 inhibitors

Certain Diabetes Drugs May Lower Risk of Dementia and Parkinson’s Disease

A recent study from researchers in South Korea contends that certain diabetes medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors may be linked to a reduced risk of developing dementia and Parkinson’s disease.
An African American man with Alzheimer's Disease holding his head

MicroRNAs Show Potential for Dementia Screening

Blood-based microRNA (miRNA) tests could diagnose mild cognitive deficits and predict the progression to Alzheimer’s disease years before it manifests clinically, research suggests.

Daily News

Related Content

Inside Precision Medicine